US Broker Ratings

Bristol-Myers Squibb (BMY) Stock Analysis: A Steady Dividend Yield with a Strategic Edge

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to capture investor attention with its robust presence in the biopharmaceutical industry. With a market capitalization of $118.71..

Stryker Corporation (SYK) Stock Analysis: Exploring an 18.45% Potential Upside in the Medical Devices Sector

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector specializing in medical devices, is captivating investor attention with its robust market position and promising potential upside. With a market..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating Revenue Challenges and Valuation Metrics

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a prominent player in the global pharmaceutical landscape, headquartered in Hyderabad, India. Operating within the healthcare sector, the company is a key..

AptarGroup, Inc. (ATR) Investor Outlook: Unpacking the 26% Potential Upside for Healthcare Investors

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector, is drawing attention with a noteworthy potential upside of 26.34%. Known for its innovative drug delivery and consumer product..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating the Potential 12.84% Upside in the Healthcare Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) has established itself as a stalwart in the medical devices industry, offering a diverse range of orthopedic reconstructive products and innovative technologies. With a..

ICON plc (ICLR)

⚠️ No article content returned.

..

Centene Corporation (CNC) Stock Analysis: Navigating Growth Challenges in the Healthcare Sector

Centene Corporation (NYSE: CNC), a significant player in the healthcare plans industry, is currently attracting considerable attention from investors. As a managed care company, Centene provides essential healthcare services across..

Boston Scientific Corporation (BSX) Stock Analysis: 66% Potential Upside with Strong Buy Ratings

Boston Scientific Corporation (NYSE: BSX), a stalwart in the healthcare sector, is capturing the spotlight with a robust potential upside of 66.15%. This intriguing figure is powered by a consensus..

Quest Diagnostics (DGX) Stock Analysis: Revenue Growth and Dividend Yield Capture Investor Attention

Quest Diagnostics Incorporated (NYSE: DGX), a leader in the healthcare sector, specifically in the diagnostics and research industry, offers a fascinating investment opportunity with its robust revenue growth and consistent..

Doximity, Inc. (DOCS) Stock Analysis: Navigating Healthcare’s Digital Frontier with Potential Upside

Doximity, Inc. (DOCS), a key player in the health information services sector, stands out as a digital platform tailored for medical professionals. With a current market cap of $4 billion,..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 24.97% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the healthcare sector, holds a commanding presence in the specialty and generic drug manufacturing industry. Based in Japan, Takeda has built..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring a Potential 27% Upside for Investors

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a titan in the healthcare sector specializing in diagnostics and research, continues to draw investor attention with its robust performance metrics and significant growth potential...

Natera, Inc. (NTRA) Stock Analysis: Navigating Growth Amidst Challenging Valuations

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector specializing in diagnostics and research, has been drawing significant attention from investors. With a rapidly growing market cap of..

Solventum Corporation (SOLV) Stock Analysis: Exploring a 4.96% Potential Upside in the Healthcare Sector

Solventum Corporation (SOLV), a key player in the healthcare sector, offers investors a compelling opportunity with a current market capitalization of $13.55 billion. Headquartered in Eagan, Minnesota, Solventum operates across..

Veeva Systems Inc. (VEEV) Stock Analysis: A 26.9% Potential Upside Beckons in the Healthcare Tech Space

Veeva Systems Inc. (NYSE: VEEV), a leading provider of cloud-based software solutions for the life sciences industry, presents a compelling opportunity for investors looking to tap into the growing intersection..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 26% Upside with Solid Buy Ratings

Alcon Inc. (NYSE: ALC), a global leader in eye care, offers a robust potential upside of 26.22% based on the latest analyst ratings. With a comprehensive suite of surgical and..

Ascendis Pharma A/S (ASND) Stock Analysis: Strong Buy Ratings and Promising Revenue Growth Capture Investor Interest

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biopharmaceutical company, is making waves in the biotechnology sector with its noteworthy financial performance and robust growth potential. Specializing in TransCon-based therapies, Ascendis..

Agilent Technologies, Inc. (A) Stock Analysis: Strong Buy Ratings Signal a Potential 22.68% Upside

Agilent Technologies, Inc. (NYSE: A) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $36.91 billion, Agilent is..

Humana Inc. (HUM) Stock Analysis: Navigating Market Dynamics with a 23.50% Revenue Growth in Healthcare Plans

Humana Inc. (NYSE: HUM), a heavyweight in the healthcare plans sector, continues to attract investor attention as it navigates through a dynamic market landscape. With a robust market capitalization of..

Genmab A/S (GMAB)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds